CBWTF logo

Auxly Cannabis Group Inc. (CBWTF)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Auxly Cannabis Group Inc. (CBWTF) with AI Score 54/100 (Hold). Auxly Cannabis Group Inc. is a Canadian consumer packaged goods company focused on the cannabis market. Market cap: 0, Sector: Healthcare.

Last analyzed: Mar 17, 2026
Auxly Cannabis Group Inc. is a Canadian consumer packaged goods company focused on the cannabis market. They develop, manufacture, and distribute a range of cannabis products for both wellness and recreational use.
54/100 AI Score

Auxly Cannabis Group Inc. (CBWTF) Healthcare & Pipeline Overview

CEOHugo Alves
Employees388
HeadquartersToronto, CA
IPO Year2017

Auxly Cannabis Group Inc. is a Canadian consumer-packaged goods company in the cannabis market, offering a diverse portfolio of cannabis products, including vapes, dried flower, concentrates, edibles, and topicals under brands like KOLAB PROJECT and Back Forty. They focus on recreational and wellness consumers in Canada.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 17, 2026

Investment Thesis

Auxly Cannabis Group Inc. presents a compelling investment thesis based on its established presence in the Canadian cannabis market and its focus on consumer-packaged goods. With a market capitalization of $0.12 billion and a price-to-earnings ratio of 4.00, the company demonstrates potential value. A gross margin of 59.5% and a profit margin of 31.1% indicate operational efficiency. Growth catalysts include expansion of its product lines and increased market penetration within Canada. Key risks include regulatory changes and competition from other cannabis producers. Investors should monitor the company's ability to maintain profitability and expand its market share in the evolving cannabis landscape.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.12 billion indicates the company's current valuation in the market.
  • P/E ratio of 4.00 suggests the stock may be undervalued compared to its earnings.
  • Profit margin of 31.1% demonstrates strong profitability in the cannabis industry.
  • Gross margin of 59.5% reflects efficient cost management in product manufacturing and sales.
  • Beta of 1.20 indicates the stock is more volatile than the overall market.

Competitors & Peers

Strengths

  • Established brands in the Canadian market.
  • Diverse product portfolio.
  • Strong distribution network.
  • Experienced management team.

Weaknesses

  • Reliance on the Canadian market.
  • Limited international presence.
  • Exposure to regulatory changes.
  • Competition from larger cannabis companies.

Catalysts

  • Ongoing: Expansion of product lines to include new cannabis-infused products.
  • Ongoing: Increased market penetration through expanded distribution networks.
  • Upcoming: Potential regulatory changes in the Canadian cannabis market.
  • Upcoming: Strategic partnerships with retailers and distributors.
  • Ongoing: Focus on developing and marketing high-margin cannabis products.

Risks

  • Potential: Increasing competition from other cannabis companies in Canada.
  • Ongoing: Changes in cannabis regulations that could impact operations.
  • Potential: Fluctuations in cannabis prices affecting profitability.
  • Ongoing: Negative consumer perception of cannabis products.
  • Potential: Difficulty in securing financing for expansion plans.

Growth Opportunities

  • Expansion of Product Lines: Auxly has the opportunity to expand its product lines to include new and innovative cannabis products, such as edibles, beverages, and wellness products. The market for cannabis-infused products is growing rapidly, driven by increasing consumer demand for alternative consumption methods. By introducing new products, Auxly can attract new customers and increase its market share. The timeline for this growth opportunity is immediate and ongoing, as Auxly continuously innovates and introduces new products to the market.
  • Increased Market Penetration: Auxly can increase its market penetration by expanding its distribution network and reaching new customers in Canada. The Canadian cannabis market is still relatively young, and there is significant potential for growth as more consumers become aware of and comfortable with cannabis products. By expanding its distribution network and increasing its marketing efforts, Auxly can reach new customers and increase its sales. The timeline for this growth opportunity is ongoing, as Auxly continues to expand its reach across Canada.
  • Strategic Partnerships: Auxly can form strategic partnerships with other companies in the cannabis industry, such as retailers, distributors, and technology providers. These partnerships can help Auxly to expand its reach, improve its efficiency, and access new technologies. For example, Auxly could partner with a retailer to open new stores or with a technology provider to develop new cannabis products. The timeline for this growth opportunity is ongoing, as Auxly continuously seeks out new partnerships to enhance its business.
  • International Expansion: Auxly can expand its operations into international markets, such as Europe and Latin America. The global cannabis market is growing rapidly, and there is significant potential for Auxly to expand its reach and increase its sales by entering new markets. However, international expansion also carries risks, such as regulatory uncertainty and competition from local players. The timeline for this growth opportunity is medium to long term, as Auxly carefully evaluates potential international markets and develops its expansion strategy.
  • Focus on High-Margin Products: Auxly can focus on developing and marketing high-margin cannabis products, such as premium flower, concentrates, and edibles. These products typically command higher prices and generate greater profits than lower-margin products, such as commodity flower. By focusing on high-margin products, Auxly can improve its profitability and increase its shareholder value. The timeline for this growth opportunity is immediate and ongoing, as Auxly continuously evaluates its product portfolio and adjusts its strategy to focus on high-margin products.

Opportunities

  • Expansion into new product categories.
  • Increased market penetration in Canada.
  • Strategic partnerships with other companies.
  • International expansion into new markets.

Threats

  • Increasing competition from other cannabis companies.
  • Changes in cannabis regulations.
  • Fluctuations in cannabis prices.
  • Negative consumer perception of cannabis.

Competitive Advantages

  • Established brands such as KOLAB PROJECT and BACK FORTY.
  • Strong distribution network across Canada.
  • Focus on product innovation and development.

About CBWTF

Auxly Cannabis Group Inc., established in 1987 and formerly known as Cannabis Wheaton Income Corp. until June 2018, is a Canadian consumer packaged goods company operating within the cannabis market. Headquartered in Toronto, the company focuses on the development, manufacturing, and distribution of a diverse range of cannabis products targeted at both wellness and recreational consumers. Auxly's product portfolio includes various forms such as vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. These products are marketed under several brands, including KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. Auxly's business model centers around creating and distributing branded cannabis products to meet the evolving demands of the Canadian market. The company aims to establish a strong presence in the cannabis industry through product innovation, brand development, and strategic partnerships. With 388 employees, Auxly is committed to delivering high-quality cannabis products and experiences to its consumers.

What They Do

  • Develops and manufactures cannabis products.
  • Distributes cannabis products across Canada.
  • Offers vape cartridges, dried flower, and concentrates.
  • Produces cannabis-infused chocolates and soft chews.
  • Sells oil drops, capsules, and topicals.
  • Markets products under the KOLAB PROJECT brand.
  • Markets products under the Dosecann brand.
  • Markets products under the BACK FORTY brand.

Business Model

  • Develops and manufactures cannabis products in-house and through partnerships.
  • Distributes products through established retail channels across Canada.
  • Focuses on branded cannabis products to build customer loyalty and market share.

Industry Context

Auxly Cannabis Group Inc. operates within the rapidly evolving Canadian cannabis industry, which has seen significant growth since legalization. The market is characterized by increasing competition, evolving consumer preferences, and ongoing regulatory changes. Auxly competes with other cannabis producers and consumer packaged goods companies, including AAWH (AWH Corp), BKUH (Akanda Corp), BXPHF (Flora Growth Corp), HLTRF (Halo Collective Inc), and JUSHF (Jushi Holdings Inc). The company's success depends on its ability to differentiate its products, build strong brands, and navigate the complex regulatory landscape.

Key Customers

  • Recreational cannabis consumers in Canada.
  • Wellness-focused consumers seeking cannabis-based products.
  • Adults of legal age in provinces and territories where cannabis is legal.
AI Confidence: 81% Updated: Mar 17, 2026

Financials

Chart & Info

Auxly Cannabis Group Inc. (CBWTF) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBWTF.

Price Targets

Wall Street price target analysis for CBWTF.

MoonshotScore

54/100

What does this score mean?

The MoonshotScore rates CBWTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Hugo Alves

CEO

Hugo Alves serves as the CEO of Auxly Cannabis Group Inc. His background includes extensive experience in the legal and cannabis industries. Prior to joining Auxly, Alves was a partner at Bennett Jones LLP, where he specialized in corporate law, with a focus on the cannabis sector. He has advised numerous cannabis companies on regulatory compliance, corporate governance, and capital markets transactions. Alves holds a law degree from Osgoode Hall Law School.

Track Record: Since becoming CEO, Hugo Alves has focused on streamlining Auxly's operations, expanding its product portfolio, and strengthening its market position in Canada. He has overseen the launch of new products, the expansion of the company's distribution network, and the implementation of cost-saving measures. Under his leadership, Auxly has achieved significant revenue growth and improved its profitability.

CBWTF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Auxly Cannabis Group Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, be undergoing restructuring, or face regulatory issues. Investing in companies on the OTC Other tier carries higher risks due to the lack of stringent listing requirements and potential for limited information availability compared to companies listed on major exchanges like the NYSE or NASDAQ.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity on the OTC market for CBWTF can be variable. Trading volume may be lower compared to major exchanges, potentially leading to wider bid-ask spreads and making it more difficult to buy or sell large quantities of shares without impacting the price. Investors should be aware of these liquidity constraints and consider using limit orders to manage their execution price.
OTC Risk Factors:
  • Limited financial disclosure increases information asymmetry.
  • Lower trading volume can lead to price volatility.
  • OTC listing may indicate financial or regulatory challenges.
  • Potential for delisting if requirements are not met.
  • Increased risk of fraud or manipulation compared to major exchanges.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Review the company's OTC Markets profile for disclosures and alerts.
  • Check for any regulatory actions or legal proceedings against the company.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • Established operations in the Canadian cannabis market.
  • Publicly traded status, even on the OTC market, provides some level of scrutiny.
  • Audited financial statements (if available) enhance transparency.
  • Experienced management team with a background in the cannabis industry.
  • Partnerships with reputable companies in the cannabis sector.

CBWTF Healthcare Stock FAQ

What does Auxly Cannabis Group Inc. do?

Auxly Cannabis Group Inc. is a consumer packaged goods company in the Canadian cannabis market. They focus on developing, manufacturing, and distributing a variety of cannabis products for both recreational and wellness consumers. Their product range includes vape cartridges, dried flower, concentrates, edibles like chocolates and soft chews, oil drops, capsules, and topicals, all marketed under brands such as KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company aims to provide diverse cannabis experiences to meet evolving consumer preferences in Canada.

What do analysts say about CBWTF stock?

Analyst coverage of Auxly Cannabis Group Inc. (CBWTF) is limited, reflecting its OTC listing and smaller market capitalization. Key valuation metrics include its P/E ratio of 4.00, which may suggest undervaluation, and its gross margin of 59.5%, indicating efficient operations. Growth considerations center on its ability to expand its market share in Canada, introduce new products, and manage regulatory risks. Investors should conduct their own due diligence and consider their risk tolerance before investing.

What are the main risks for CBWTF?

The main risks for Auxly Cannabis Group Inc. include increasing competition in the Canadian cannabis market, regulatory changes that could impact its operations, and fluctuations in cannabis prices that could affect its profitability. As an OTC-listed company, CBWTF also faces risks related to liquidity and information disclosure. Negative consumer perception of cannabis products and difficulty in securing financing for expansion plans are additional challenges. Investors should carefully consider these risks before investing in CBWTF.

What are the key growth opportunities for CBWTF in healthcare?

Auxly Cannabis Group Inc. can capitalize on growth opportunities within the healthcare sector by expanding its product lines to include cannabis-based wellness and therapeutic products. This includes developing formulations targeting specific health conditions, such as pain management, anxiety, and sleep disorders. Strategic partnerships with healthcare providers and research institutions can also facilitate the development and validation of these products. Additionally, Auxly can explore opportunities in the medical cannabis market, which often commands higher margins and greater regulatory support.

How does Auxly Cannabis Group Inc. navigate regulatory approval processes?

As a cannabis company operating in Canada, Auxly Cannabis Group Inc. navigates regulatory approval processes by adhering to the regulations set forth by Health Canada. This includes obtaining licenses for cultivation, processing, and distribution, as well as complying with strict quality control standards. Auxly also engages with regulatory bodies to stay informed about upcoming changes and to advocate for policies that support the growth of the cannabis industry. Furthermore, the company invests in research and development to ensure its products meet regulatory requirements and consumer safety standards.

What are the key factors to evaluate for CBWTF?

Auxly Cannabis Group Inc. (CBWTF) currently holds an AI score of 54/100, indicating moderate score. Key strength: Established brands in the Canadian market.. Primary risk to monitor: Potential: Increasing competition from other cannabis companies in Canada.. This is not financial advice.

How frequently does CBWTF data refresh on this page?

CBWTF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CBWTF's recent stock price performance?

Recent price movement in Auxly Cannabis Group Inc. (CBWTF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brands in the Canadian market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • OTC data may be less reliable than exchange-listed data.
  • AI analysis pending may provide additional insights in the future.
Data Sources

Popular Stocks